CLINICAL_TRIALS
trial_result
· 2020-06-18
Clinical Trial Update: Cetuximab Rechallenge Study [Phase 2]
Summary
Phase 2 trial update on cetuximab rechallenge for metastatic colorectal cancer has completed enrollment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese University of Hong Kong | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED